全关节置换术前骨质疏松常见且治疗不足
该回顾性病例系列纳入200例择期全关节置换术成人,评估术前骨质疏松筛查与治疗率。119例(59.5%)符合双能X线吸收检测标准,其中仅21例(17.6%)术前2年内接受检测,33%据T值诊断骨质疏松;49例(24.5%)符合药物治疗标准,仅11例在术前或术后6个月内获得处方。
要点
- 59.5%(119/200)全关节置换患者符合双能X线吸收检测标准,仅17.6%(21/119)术前2年内接受检测。
- 24.5%(49/200)符合美国国家骨质疏松基金会药物治疗标准,仅11/49在术前或术后6个月内获处方。
- 作者认为术前骨质疏松筛查与治疗不足可能增加假体周围骨折风险。
核心结论
- 四分之一的全关节置换患者符合接受骨质疏松药物治疗的标准,但仅5%在术前或术后接受治疗。
- 术前骨质疏松筛查与治疗的缺乏可能增加假体周围骨折风险。
研究设计与样本
- 回顾性病例系列,纳入200例连续成人(106例女性,94例男性),年龄48-92岁,在单一三级中心接受择期全关节置换术(100例全髋,100例全膝)。
- 回顾病历确定术前骨质疏松危险因素、既往双能X线吸收检测及既往骨质疏松药物治疗。
- 使用骨折风险评估工具估算骨折风险,并对所有患者应用美国国家骨质疏松基金会筛查与治疗标准。
主要发现
- 200例中119例(59.5%)符合双能X线吸收检测标准。
- 119例中21例(17.6%)在术前2年内接受双能X线吸收检测,33%据T值诊断骨质疏松。
- 200例中49例(24.5%)符合美国国家骨质疏松基金会药物治疗标准,其中11例在术前或术后6个月内获得药物治疗处方。
关键数值与推荐
- 符合双能X线吸收检测标准:119/200例(59.5%)。
- 符合检测者中术前2年内实际检测:21/119例(17.6%)。
- 检测者中据T值诊断骨质疏松:33%。
- 符合美国国家骨质疏松基金会药物治疗标准:49/200例(24.5%)。
- 符合药物治疗标准者中术前或术后6个月内获处方:11/49例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoporosis is common in total joint arthroplasty (TJA) patients and likely contributes to the increasing incidence of periprosthetic fracture. Despite this, the prevalence of osteoporosis in patients undergoing elective TJA is inadequately studied. We hypothesize that preoperative osteoporosis is underrecognized and undertreated in the TJA population. The purpose of this study is to report preoperative osteoporosis screening rates and prevalence prior to TJA and rates of pharmacologic osteoporosis treatment in the TJA population. METHODS: This is a retrospective case series of 200 consecutive adults (106F, 94M) aged 48-92 years who underwent elective TJA (100 total hip, 100 total knee) at a single tertiary-care center. Charts were retrospectively reviewed to determine preoperative osteoporosis risk factors, prior dual-energy X-ray absorptiometry (DXA) testing, and prior osteoporosis pharmacotherapy. Fracture risk was estimated using the Fracture Risk Assessment Tool and the National Osteoporosis Foundation criteria for screening and treatment were applied to all patients. RESULTS: One hundred nineteen of 200 patients (59.5%) met criteria for DXA testing. Of these 119, 21 (17.6%) had DXA testing in the 2 years prior to surgery, and 33% had osteoporosis by T-score. Forty-nine patients (24.5%) met National Osteoporosis Foundation criteria for pharmacologic osteoporosis treatment, and 11 of these 49 received a prescription for pharmacotherapy within 6 months before or after surgery. CONCLUSION: One quarter of TJA patients meet criteria to receive osteoporosis medications, but only 5% receive therapy preoperatively or postoperatively. This lack of preoperative osteoporosis screening and treatment may contribute to periprosthetic fracture risk.
引用
- Bernatz JT, Brooks AE, Squire MW, et al. Osteoporosis Is Common and Undertreated Prior to Total Joint Arthroplasty. J Arthroplasty. 2019. PMID: 30992237. doi:10.1016/j.arth.2019.03.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。